Intravascular Neuro OCT Imaging System for Aneurysm Treatment Evaluation
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Spryte Medical
- Study ID
- NCT07214220
- Status
- Recruiting
Conditions
- Intracranial Aneurysm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Endovascular Intracranial aneurysm treatment — PROCEDUREEndovascular Intracranial aneurysm treatment using devices such as coils, flow diverters, etc. The treatment will include devices that are all FDA approved.
- nOCT imaging — DEVICEDuring the aneurysm treatment and during the subsequent follow-up, nOCT imaging will be performed.
Study Details
This is an investigational study for a new medical device called the nOCT (neuro optical coherence tomography) Imaging System, which is manufactured by Spryte Medical, LLC. The nOCT Imaging System takes pictures from inside a blood vessel in your brain. These pictures give your doctor information about the inside of your blood vessel including the disease and any implanted devices. The nOCT Imaging System consists of a probe and a console. The probe is a small, flexible wire-like device designed to navigate through catheters which have already been inserted in your body as part of your planned procedure. Catheters are small, flexible, tubes inserted in your blood vessels which allow your doctor to deliver treatments such as medications, coils, or stents directly to the affected area. The console is a unit that includes a computer, screen and laser light source. The probe is connected to the console. The console provides the probe with low-power light from the laser which is used to scan and create pictures of your blood vessel. The pictures are displayed on the screen of the console for review by your doctor and may be stored for future viewing. The objective of the study is to evaluate the safety and effectiveness of the nOCT Imaging System to provide quality images for diagnostic assessment during endovascular intracranial aneurysm treatment and follow-up.
Key Dates
- Start date
- Feb 25, 2026
- Status verified
- May 2026
- Primary completion
- Jul 7, 2026
- Completion
- Feb 28, 2029
Study Design
- Enrollment
- 67 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: Single arm: Use of nOCT during treatment and follow-upUse of nOCT during intracranial aneurysm treatment and subsequent follow-up
Primary Outcome Measure
Safety - Adverse Events [ Time Frame: peri-procedural ]
Locations (6)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Baptist Health Research Institute | Jacksonville | Florida | 32207 | |
| Tampa General Hospital | Tampa | Florida | 33606 | |
| Advocate Aurora Research Institute | Park Ridge | Illinois | 60068 | |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | |
| Tufts Medical Center, Inc. | Boston | Massachusetts | 02111 | |
| University at Buffalo Neurosurgery (UBNS) | Buffalo | New York | 14203 |
Find similar trials in Jacksonville, FL
Related Studies
- Product Surveillance RegistryRecruiting · Medtronic · Birmingham, Alabama
- The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).Recruiting · Medtronic Neurovascular Clinical Affairs · Englewood, Colorado
- International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)Recruiting · Montefiore Medical Center · Coral Gables, Florida
- NV PSR INSPIRE-A Pipeline™ Vantage Post Approval StudyRecruiting · Medtronic Neurovascular Clinical Affairs · Jacksonville, Florida